# Genotype Guided Versus Conventional Approach in Selection of Oral P2Y12 Receptor Blocker in Chinese Patients Suffering From Acute Coronary Syndrome

Study · id `cardio:ct-nct01994941` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01994941](<https://clinicaltrials.gov/study/NCT01994941>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01994941

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 133 participants.

## Technical summary

Registry record NCT01994941. Randomized; no masking; primary purpose treatment. Start 2013-08 (registry gives no type); primary completion 2015-08 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 133 participants (enrolled count; ClinicalTrials.gov record NCT01994941, source copy `cardio:ctgov-nct01994941-2015-12-02`, retrieved 2026-10-31)
- Start date: 2013-08 (registry gives no type) (ClinicalTrials.gov record NCT01994941, source copy `cardio:ctgov-nct01994941-2015-12-02`, retrieved 2026-10-31)
- Primary completion: 2015-08 (actual) (ClinicalTrials.gov record NCT01994941, source copy `cardio:ctgov-nct01994941-2015-12-02`, retrieved 2026-10-31)
- Completion: 2015-08 (actual) (ClinicalTrials.gov record NCT01994941, source copy `cardio:ctgov-nct01994941-2015-12-02`, retrieved 2026-10-31)
- Countries: Hong Kong SAR China (ClinicalTrials.gov record NCT01994941, source copy `cardio:ctgov-nct01994941-2015-12-02`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01994941-2015-12-02`, retrieved 2026-10-31)

## The registry's words

- Brief title: Genotype Guided Versus Conventional Approach in Selection of Oral P2Y12 Receptor Blocker in Chinese Patients Suffering From Acute Coronary Syndrome
- Condition: Acute Coronary Syndrome
- Intervention (Drug): Clopidogrel
- Intervention (Drug): Ticagrelor
- Lead sponsor: The University of Hong Kong
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry intervention name matches this record: Clopidogrel (`cardio:clopidogrel`)
- Registry intervention name matches this record: Ticagrelor (`cardio:ticagrelor`)
- Registry intervention is a member of this class by a sourced record link: P2Y12 inhibitors (drug class) (`cardio:p2y12-inhibitors`)
- Registry lists this organization as the lead sponsor: The University of Hong Kong (`cardio:org-the-university-of-hong-kong`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Genotyping-guided approach versus the conventional approach in selection of oral P2Y12 receptor blockers in Chinese patients suffering from acute coronary syndrome (`cardio:pubmed-28222641`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 182296228eece99224d6dfcf2e6e8810672402fe0f6e70f7e57db4ba8ce43ca0
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
